Literature DB >> 12096580

Cost-effectiveness of wound management in France: pressure ulcers and venous leg ulcers.

S Meaume1, E Gemmen.   

Abstract

OBJECTIVES: This study set out to define realistic protocols of care for the treatment of chronic venous leg ulcers and pressure ulcers in France and, by developing cost-effectiveness models, to compare the different protocols of care for the two ulcer groups, enabling a calculation of direct medical costs per ulcer healed in a typical French health insurance plan.
METHOD: Clinical outcomes and some treatment patterns were obtained from published literature. Validations of different treatment patterns were developed using an expert consensus panel similar to the Delphi approach. Costs were calculated based on national averages and estimates from the UK and Germany. The models were used to measure costs per healed ulcer over a 12-week period.
RESULTS: For both the pressure ulcer and venous leg ulcer models, three protocols of care were identified. For pressure ulcers and venous leg ulcers, the hydrocolloid DuoDERM (ConvaTec, also known as Granuflex in the UK and Varihesive in Germany) was most cost-effective in France.
CONCLUSION: The combination of published data and expert consensus opinion is a valid technique, and in this case suggests that treating pressure ulcers and venous leg ulcers with hydrocolloid dressings is more cost-effective than treating them with saline gauze, in spite of the lower unit cost of the latter.

Entities:  

Mesh:

Year:  2002        PMID: 12096580     DOI: 10.12968/jowc.2002.11.6.26408

Source DB:  PubMed          Journal:  J Wound Care        ISSN: 0969-0700            Impact factor:   2.072


  6 in total

1.  Wound healing university diplomas in France: an impact measurement after 6 years.

Authors:  Sylvie Meaume; Luc Téot; O Dereure
Journal:  Int Wound J       Date:  2005-06       Impact factor: 3.315

2.  Cost-effective faster wound healing with a sustained silver-releasing foam dressing in delayed healing leg ulcers--a health-economic analysis.

Authors:  Elizabeth Scanlon; Tonny Karlsmark; David J Leaper; Kate Carter; Peter B Poulsen; Kristian Hart-Hansen; Tina W Hahn
Journal:  Int Wound J       Date:  2005-06       Impact factor: 3.315

Review 3.  Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers.

Authors:  Astrid Langer; Wolf Rogowski
Journal:  BMC Health Serv Res       Date:  2009-07-10       Impact factor: 2.655

Review 4.  Current Therapeutic Strategies in Diabetic Foot Ulcers.

Authors:  Aurelio Perez-Favila; Margarita L Martinez-Fierro; Jessica G Rodriguez-Lazalde; Miguel A Cid-Baez; Michelle de J Zamudio-Osuna; Ma Del Rosario Martinez-Blanco; Fabiana E Mollinedo-Montaño; Iram P Rodriguez-Sanchez; Rodrigo Castañeda-Miranda; Idalia Garza-Veloz
Journal:  Medicina (Kaunas)       Date:  2019-10-25       Impact factor: 2.430

5.  Skin Substitutes for Adults With Diabetic Foot Ulcers and Venous Leg Ulcers: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2021-06-04

6.  The Scientific Basis and Advantage of Human Experiential Assessment in the quality control of Chinese Herbal Medicines exampling as Schisandrae Chinensis Fructus.

Authors:  Yongfeng Zhou; Dingkun Zhang; Haotian Li; Haizhu Zhang; Jixiang Fang; Yanqin Ma; Ping Zhang; Jiabo Wang; Xiaohe Xiao
Journal:  Sci Rep       Date:  2018-04-09       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.